CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock Payable [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Mar. 31, 2020	$ 3,400	$ 45,585	$ 54,094,848	$ 1,000,000	$ (53,521,700)	$ 1,622,133
Beginning balance (in shares) at Mar. 31, 2020	3,400,000	45,585,592
Common shares issued upon exercise of warrants		$ 288	258,612			258,900
Common shares issued upon exercise of warrants (in shares)		287,666
Preferred stock conversion	$ (3,400)	$ 3,400
Preferred stock conversion (in shares)	(3,400,000)	3,400,000
Common shares issued in connection with offerings		$ 9,750	3,890,250	(1,000,000)		2,900,000
Common shares issued in connection with offerings (in shares)		9,750,000
Common shares issued to non-employees and employees		$ 472	486,828			487,300
Common shares issued to non-employees and employees (in shares)		472,000
Stock Option expense			661,959			661,959
Stock Option exercise		$ 116	61,364			61,480
Stock Option exercise (in shares)		116,000
Stock Payable				1,999,998		1,999,998
Net (loss)					(3,021,003)	(3,021,003)
Ending balance at Jun. 30, 2020		$ 59,611	59,453,861	1,999,998	(56,542,703)	4,970,767
Ending balance (in shares) at Jun. 30, 2020		59,611,258
Beginning balance at Mar. 31, 2020	$ 3,400	$ 45,585	54,094,848	1,000,000	(53,521,700)	1,622,133
Beginning balance (in shares) at Mar. 31, 2020	3,400,000	45,585,592
Net (loss)						(11,742,965)
Ending balance at Dec. 31, 2020		$ 73,637	67,010,711		(65,264,665)	1,819,683
Ending balance (in shares) at Dec. 31, 2020		73,637,115
Beginning balance at Jun. 30, 2020		$ 59,611	59,453,861	1,999,998	(56,542,703)	4,970,767
Beginning balance (in shares) at Jun. 30, 2020		59,611,258
Common shares issued upon exercise of warrants		$ 8,839	4,555,484			4,564,323
Common shares issued upon exercise of warrants (in shares)		8,839,399
Common shares issued in connection with offerings		$ 4,444	1,995,554	$ (1,999,998)
Common shares issued in connection with offerings (in shares)		4,444,440
Common shares issued to non-employees		$ 191	326,408			326,599
Common shares issued to non-employees (in shares)		191,136
Stock Option expense			204,594			204,594
Stock Option exercise		$ 236	(236)
Stock Option exercise (in shares)		236,239
Net (loss)					(4,361,628)	(4,361,628)
Ending balance at Sep. 30, 2020	$ 73,322,472	$ 66,535,665			(60,904,331)	5,704,655
Ending balance (in shares) at Sep. 30, 2020		73,321
Common shares issued upon exercise of warrants		$ 167	91,498			91,665
Common shares issued upon exercise of warrants (in shares)		166,666
Common shares issued to employees		$ 50	49,950			50,000
Common shares issued to employees (in shares)		50,000
Common shares issued to non-employees		$ 99	119,900			119,999
Common shares issued to non-employees (in shares)		97,977
Stock Option expense			213,698			213,698
Net (loss)					(4,360,334)	(4,360,334)
Ending balance at Dec. 31, 2020		$ 73,637	67,010,711		(65,264,665)	1,819,683
Ending balance (in shares) at Dec. 31, 2020		73,637,115
Beginning balance at Mar. 31, 2021		$ 87,464	80,857,742		(69,931,220)	11,013,986
Beginning balance (in shares) at Mar. 31, 2021		87,465,178
Preferred stock issuance	$ 6,681		2,220,350			2,227,031
Preferred stock issuance (in shares)	6,681,090
Common shares issued upon exercise of warrants		$ 1,278	651,499			652,777
Common shares issued upon exercise of warrants (in shares)		1,277,777
Common shares issued to non-employees and employees		$ 856	39,144			40,000
Common shares issued to non-employees and employees (in shares)		855,499
Stock option and RSU-related stock compensation expense			651,648			651,648
Stock Option exercise		$ 163	48,068			48,231
Stock Option exercise (in shares)		162,668
Net (loss)					(7,425,626)	(7,425,626)
Ending balance at Jun. 30, 2021	$ 6,681	$ 89,761	84,468,451		(77,356,846)	7,208,047
Ending balance (in shares) at Jun. 30, 2021	6,681,090	89,761,122
Beginning balance at Mar. 31, 2021		$ 87,464	80,857,742		(69,931,220)	11,013,986
Beginning balance (in shares) at Mar. 31, 2021		87,465,178
Net (loss)						(28,540,132)
Ending balance at Dec. 31, 2021	$ 4,454	$ 107,244	106,293,256		(98,471,352)	7,933,602
Ending balance (in shares) at Dec. 31, 2021	4,454,060	107,242,070
Beginning balance at Jun. 30, 2021	$ 6,681	$ 89,761	84,468,451		(77,356,846)	7,208,047
Beginning balance (in shares) at Jun. 30, 2021	6,681,090	89,761,122
Common shares issued upon exercise of warrants		$ 9,526	11,894,694			11,904,220
Common shares issued upon exercise of warrants (in shares)		9,523,376
Common shares issued in connection with offerings		$ 4,757	4,990,493			4,995,250
Common shares issued in connection with offerings (in shares)		4,757,381
Common shares issued to non-employees		$ 173	307,546			307,719
Common shares issued to non-employees (in shares)		172,802
Stock option and RSU-related stock compensation expense			625,556			625,556
Stock Option exercise		$ 118	59,832			59,950
Stock Option exercise (in shares)		118,692
Net (loss)					(10,378,473)	(10,378,473)
Ending balance at Sep. 30, 2021	$ 6,681	$ 104,335	102,346,572		(87,735,319)	14,722,269
Ending balance (in shares) at Sep. 30, 2021	6,681,090	104,333,373
Common shares issued upon exercise of warrants		$ 667	832,649			833,316
Common shares issued upon exercise of warrants (in shares)		666,667
Preferred stock conversion	$ (2,227)	$ 2,227
Preferred stock conversion (in shares)	(2,227,030)	2,227,030
Common shares issued to non-employees		$ 15	20,685			20,700
Common shares issued to non-employees (in shares)		15,000
Stock option and RSU-related stock compensation expense			3,093,350			3,093,350
Net (loss)					(10,736,033)	(10,736,033)
Ending balance at Dec. 31, 2021	$ 4,454	$ 107,244	$ 106,293,256		$ (98,471,352)	$ 7,933,602
Ending balance (in shares) at Dec. 31, 2021	4,454,060	107,242,070